oxfordbio.com oxfordbio.com

oxfordbio.com

Oxford Cancer Biomarkers |

Pioneering biomarker technologies for Cancer therapies. Our biomarkers are used to identify the right patient, the right drug and the right dose. Using our biomarker tests provides more effective treatment for patients and economic savings for the healthcare system. Our colorectal cancer tests are validated using thousands of patient samples and are set to transform the current treatment pathway. ColoTox – Predicts chemotherapy toxicity – Now Available. March 7, 2018. Oxford developed prognostic assay fo...

http://www.oxfordbio.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR OXFORDBIO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.0 out of 5 with 5 reviews
5 star
2
4 star
0
3 star
1
2 star
0
1 star
2

Hey there! Start your review of oxfordbio.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.2 seconds

FAVICON PREVIEW

  • oxfordbio.com

    16x16

  • oxfordbio.com

    32x32

  • oxfordbio.com

    64x64

  • oxfordbio.com

    128x128

  • oxfordbio.com

    160x160

  • oxfordbio.com

    192x192

  • oxfordbio.com

    256x256

CONTACTS AT OXFORDBIO.COM

Roberto Simi

11 Wes●●●●●●d Road

Did●●●ury

Man●●●ter , Lancashire, M20 2UB

United Kingdom

44.07●●●●●64400
ro●●●●●●●●●●@hotmail.com

View this contact

Roberto Simi

11 Wes●●●●●●d Road

Did●●●ury

Man●●●ter , Lancashire, M20 2UB

United Kingdom

44.07●●●●●64400
ro●●●●●●●●●●@hotmail.com

View this contact

Roberto Simi

11 Wes●●●●●●d Road

Did●●●ury

Man●●●ter , Lancashire, M20 2UB

United Kingdom

44.07●●●●●64400
ro●●●●●●●●●●@hotmail.com

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2012 April 19
UPDATED
2014 April 05
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 12

    YEARS

  • 1

    MONTHS

  • 18

    DAYS

NAME SERVERS

1
ns23.domaincontrol.com
2
ns24.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

SCORE

6.2

PAGE TITLE
Oxford Cancer Biomarkers | | oxfordbio.com Reviews
<META>
DESCRIPTION
Pioneering biomarker technologies for Cancer therapies. Our biomarkers are used to identify the right patient, the right drug and the right dose. Using our biomarker tests provides more effective treatment for patients and economic savings for the healthcare system. Our colorectal cancer tests are validated using thousands of patient samples and are set to transform the current treatment pathway. ColoTox – Predicts chemotherapy toxicity – Now Available. March 7, 2018. Oxford developed prognostic assay fo...
<META>
KEYWORDS
1 biomarker tests
2 biomarker platforms
3 about us
4 additional reading
5 news
6 publications
7 cancernav
8 toxnav
9 and toxnav
10 coupons
CONTENT
Page content here
KEYWORDS ON
PAGE
biomarker tests,biomarker platforms,about us,additional reading,news,publications,cancernav,toxnav,and toxnav
SERVER
Microsoft-IIS/10.0
POWERED BY
PHP/5.6.34,ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Oxford Cancer Biomarkers | | oxfordbio.com Reviews

https://oxfordbio.com

Pioneering biomarker technologies for Cancer therapies. Our biomarkers are used to identify the right patient, the right drug and the right dose. Using our biomarker tests provides more effective treatment for patients and economic savings for the healthcare system. Our colorectal cancer tests are validated using thousands of patient samples and are set to transform the current treatment pathway. ColoTox – Predicts chemotherapy toxicity – Now Available. March 7, 2018. Oxford developed prognostic assay fo...

INTERNAL PAGES

oxfordbio.com oxfordbio.com
1

Oxford Cancer Biomarkers | Biomarker platforms

http://www.oxfordbio.com/biomarker-platforms

Our approach to companion diagnostic biomarker discovery. Cancer therapy is dictated by risk benefit ratios. For every new therapeutic approved by regulatory agencies, every time a drug is assessed for reimbursement and every time a drug is prescribed in the clinic the Pros (Drug efficacy) are weighed against the Cons (Drug toxicity and cost) as the risk benefit ratio. 8211; anti-cancer drug efficacy biomarkers. Identifies genes that influence the sensitivity of tumour cells to cancer drugs. Toxgnostic m...

2

Oxford Cancer Biomarkers | Oxford Cancer Biomarkers announces issued United States patent

http://www.oxfordbio.com/oxford-cancer-biomarkers-announces-issued-united-states-patent

Oxford Cancer Biomarkers announces issued United States patent. Oxford, UK, 24 July 2014. Nick La Thangue, CSO of Oxford Cancer Biomarkers, commented: The issue of the United States patent is a major step forward in strengthening OCB’s position in biomarker discovery for personalised cancer medicine. It is an important milestone in attracting new partners to work with us. About Oxford Cancer Biomarkers. For more information, please visit www.oxfordcancerbiomarkers.com.

3

Oxford Cancer Biomarkers | Oxford Cancer Biomarkers announces biomarker discovery and development deal with Daiichi-Sankyo

http://www.oxfordbio.com/oxford-cancer-biomarkers-announces-biomarker-discovery-and-development-deal-with-daiichi-sankyo

Oxford Cancer Biomarkers announces biomarker discovery and development deal with Daiichi-Sankyo. Oxford, UK, 29th August 2014. Oxford Cancer Biomarkers Ltd (OCB), the UK-based company developing tests that allow medicines to be personalised for the benefit of the cancer patient, has today announced an agreement with Daiichi-Sankyo for biomarker discovery, with the potential for further collaboration on validation and development of resulting biomarkers. About Oxford Cancer Biomarkers. Oxford Cancer Bioma...

4

Oxford Cancer Biomarkers | Biomarker tests

http://www.oxfordbio.com/biomarker-tests

Colorectal cancer biomarker products. We offer a suite of biomarker products for use in the management of colorectal cancer. These biomarker products will transform the standard of care for colorectal cancer by providing robust data for clinical decision making, thereby delivering clinical benefits that improve patient outcomes and substantially reducing treatment costs. Defines a subpopulation of normal individuals with an elevated risk of developing colorectal cancer. 29, 19, 20, 25-28. And are current...

5

Oxford Cancer Biomarkers | Additional reading

http://www.oxfordbio.com/additional-reading

Colorectal cancer, which includes primary cancer of the colon and rectum, is the third most common cancer in men and second for women in the world, based on GLOBOCAN statistics current at 2008. This accounts for 1.2 million new cases of colorectal cancer per year and 608,000 deaths attributed to this disease. Approximately 70-80% of newly diagnosed cases of CRC undergo curative resection, however 40% of these develop incurable recurrent disease due to undetected micrometastases.

UPGRADE TO PREMIUM TO VIEW 4 MORE

TOTAL PAGES IN THIS WEBSITE

9

LINKS TO THIS WEBSITE

oxfordcancerbiomarkers.com oxfordcancerbiomarkers.com

Oxford Cancer Biomarkers | Biomarker platforms

http://www.oxfordcancerbiomarkers.com/biomarker-platforms

Our approach to companion diagnostic biomarker discovery. Cancer therapy is dictated by risk benefit ratios. For every new therapeutic approved by regulatory agencies, every time a drug is assessed for reimbursement and every time a drug is prescribed in the clinic the Pros (Drug efficacy) are weighed against the Cons (Drug toxicity and cost) as the risk benefit ratio. 8211; anti-cancer drug efficacy biomarkers. Identifies genes that influence the sensitivity of tumour cells to cancer drugs. Toxgnostic m...

oxfordcancerbiomarkers.com oxfordcancerbiomarkers.com

Oxford Cancer Biomarkers | About us

http://www.oxfordcancerbiomarkers.com/about-us

Pioneering personalised cancer medicine. Oxford Cancer Biomarkers (OCB) develops and commercialises biomarker tests that enable better informed treatment decisions. Using our biomarker tests provides more effective treatment for patients and economic savings for the healthcare system. An Oxford University spin-out company. A specialist team based in Oxford Science Park. Nick LaThangue BSc MSc PhD, MA CEO/Chief Scientific Officer. David is a founder of OCB and Professor of Cancer Medicine at the Universit...

oxfordcancerbiomarkers.com oxfordcancerbiomarkers.com

Oxford Cancer Biomarkers | Biomarker tests

http://www.oxfordcancerbiomarkers.com/Biomarker-tests

Colorectal cancer biomarker products. We offer a suite of biomarker products for use in the management of colorectal cancer. These biomarker products will transform the standard of care for colorectal cancer by providing robust data for clinical decision making, thereby delivering clinical benefits that improve patient outcomes and substantially reducing treatment costs. Defines a subpopulation of normal individuals with an elevated risk of developing colorectal cancer. 29, 19, 20, 25-28. And are current...

oxfordcancerbiomarkers.com oxfordcancerbiomarkers.com

Oxford Cancer Biomarkers | News

http://www.oxfordcancerbiomarkers.com/News

Oxford Cancer Biomarkers appoints Kathryn Kuhne as its Commercial and Marketing Director. Oxford, UK, 10 June 2016. Oxford Cancer Biomarkers has appointed Kathryn Kuhne as Commercial and Marketing Director, a key growth milestone for the company which aims to benefit cancer patients through developing molecular diagnostic tests that allow improved treatment decisions. About Oxford Cancer Biomarkers. For more information, please visit: http:/ www.oxfordcancerbiomarkers.com. Oxford Cancer Biomarkers Ltd.

oxfordcancersolutions.com oxfordcancersolutions.com

About us - Oxford cancer solutions

http://www.oxfordcancersolutions.com/AboutUs

Oxford Cancer Solutions (OCS) is a business unit of Oxford Cancer Biomarkers (OCB). Dedicated to helping public and private health providers deliver better value cancer care. Oxford Cancer Biomarkers is a 2011 spin-out from Oxford University founded by Prof David Kerr and Prof Nick La Thangue. In early 2012 it raised 3M from an investment by Quintiles Inc, the leading international pharma services organisation. Your browser does not support the video tag. Find out more about our highly experienced team.

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL LINKS TO THIS WEBSITE

10

OTHER SITES

oxfordbiketours.co.uk oxfordbiketours.co.uk

Oxford Bike Tours | Bicycle tours of Colleges, City and River

8212; Main Menu —. Hop on a bike and explore this beautiful and fascinating city. There’s an emphasis on having FUN whilst seeing as much of the city as possible. Get off the beaten track and discover hidden gems with our engaging, entertaining and knowledgeable guides. We offer tours of the City or out along the river into the countryside. It doesn’t matter if you are a single traveller, a family, or even a hen party, you are going to have a great time. I’d love to tell you more but it would spoil it!

oxfordbikeweek.co.uk oxfordbikeweek.co.uk

Oxford Bike Week | 9 – 17 June 2018

Oxford Bike Week 9 – 17 June 2018. Everyday cycling for everybody! Pop up green events across Oxford from 17-25 June 2017. Follow me on Twitter. Bike Week 2018 will take place on 9-17 June. Women in Oxford bike tour. Photo credit: Bjorn Eiben. Oxford Bike Week 2017 – Thanks. Isis Stop’N’Stare Ride, 13 June 2017. Thanks to all the organisers, ride leaders and sweepers and riders who took part in Oxford Bike Week – we hope that you all enjoyed the events and rides! Be sure to check out our photos page.

oxfordbikeworks.co.uk oxfordbikeworks.co.uk

Oxford Bike Works

Built To Go Far. Affordable Custom-Built Touring Bikes from Oxford Bike Works, UK. Our bespoke adventure bikes are designed to be more comfortable, lighter, better value and better looking than our competitors, with a comprehensive guarantee. We build top quality touring and expedition bikes from our workshop in Oxfordshire. Tailored To Your Needs. Every rider has different aspirations. If you buy an off-the-peg bike, you have to accept someone else's choices. With us, the choices are all yours. Richard ...

oxfordbim.com oxfordbim.com

事故車の処分なら|中古車専門の販売店に引き取ってもらおう

バイク回収 オートバイ売るなら 評判のパッション 査定額が10秒で出る自動査定.

oxfordbingo.co.uk oxfordbingo.co.uk

The Oxford Bingo Club, Whitstable - Home

The Oxford Bingo Club Ltd. 16-18 Oxford Street, Whitstable Kent. To Saturday Evenings from 5:30pm, and Friday and Saturday afternoons from 12:00 noon. More will appear here soon, but for more information please call 01227 272736 during opening times.

oxfordbio.com oxfordbio.com

Oxford Cancer Biomarkers |

Pioneering biomarker technologies for Cancer therapies. Our biomarkers are used to identify the right patient, the right drug and the right dose. Using our biomarker tests provides more effective treatment for patients and economic savings for the healthcare system. Our colorectal cancer tests are validated using thousands of patient samples and are set to transform the current treatment pathway. ColoTox – Predicts chemotherapy toxicity – Now Available. March 7, 2018. Oxford developed prognostic assay fo...

oxfordbiobank.org.uk oxfordbiobank.org.uk

Oxford BioBank

Why should I take part? What do I need to do to take part? What is it like taking part? What happens after my visit? What makes the Oxford BioBank unique? Consent & Withdrawal. Publications on Google Scholar. The Oxford Biobank investigations focus on research into common diseases like diabetes, obesity and cardiovascular disease. If you have visited the Oxford BioBank and would like to comment on your experiences, please visit our Feedback Page. This website uses cookies to improve your experience. ...

oxfordbiochar.com oxfordbiochar.com

Oxford Biochar - Home

Biochar is the carbon rich product obtained by the pyrolysis of biomass (heating under oxygen-deprived conditions). Watch our VIDEO. We are excited to announce new partnerships with Four Seasons Fuel. And the Oxford Charcoal Company. 2016: Oxford Biochar, Coventry University and Garden Organics cooperation on citizen science.

oxfordbioconcepts.com oxfordbioconcepts.com

Oxford Bioconcepts

Consultancy to the International Life Science Sector. M: 44 (0)791 2218335. Registered Address: Cox Hinkins and Co, Charterford House, 75 London Road, Oxford, OX3 9BB. Registered in England, No. 6368031.

oxfordbiodynamics.com oxfordbiodynamics.com

Home | Oxford Biodynamics

Board & Governance. Chromosome conformation signatures response to methotrexate in early rheumatoid arthritis. Directors Talk highlights OBD’s achievements on ALS project. OBD presents latest ALS biomarker data at the 6th World CNS Summit. Annual Report and Accounts for the year ended 30 Sep 2017 published. Oxford BioDynamics announces grant of Indian patent for its proprietary technology platform, EpiSwitch . We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch.

oxfordbioelectronics.com oxfordbioelectronics.com

Oxford Bioelectronics | Linking technology with physiology |

Linking technology with physiology. Pioneering advances in the emerging field of bioelectronics. Bioelectronics is an exciting new area of medicine which is transforming the way we think about and treat the human body. Advances in this pioneering field are already being tipped to rewrite the medical textbooks. Gregory B. Diette, MD, MHS. Johns Hopkins University School of medicine. Pulmonologist, Intensivist and Epidemiologist for two decades. He is a member of the American Thoracic Society. Lorem ipsum ...